Live News Categoriesequity

LTR Pharma Limited (LTP.AX) News

Follow LTR Pharma Limited (LTP.AX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol LTP.AX Asset equity Sector Markets 90 days 1 Last 0.53 Updated Oct 06, 2026, 02:50 AM UTC Open live news feed Open LTP.AX chart & news

M LTR Pharma drug ROXUS begins US prescription fulfillment Shares of LTR Pharma (LTP.AX) rose as much as 13.3% to A$0.560 after the company said its erectile dysfunction treatment ROXUS began prescription fulfillment in the US via online platform Mavrox. The stock is down 28.3% EQUITY | Oct 06, 2026, 02:50 AM UTC